2021 Q4 Form 10-Q Financial Statement

#000185173421000017 Filed on October 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $2.449M $1.805M $1.007M
YoY Change 72.46% 79.25% 272.96%
Cost Of Revenue $1.711M $1.094M $688.0K
YoY Change 82.02% 59.01% 330.0%
Gross Profit $738.0K $711.0K $319.0K
YoY Change 57.02% 122.88% 190.0%
Gross Profit Margin 30.13% 39.39% 31.68%
Selling, General & Admin $4.066M $4.654M $3.255M
YoY Change 9.89% 42.98% 73.14%
% of Gross Profit 550.95% 654.57% 1020.38%
Research & Development $1.911M $2.076M $927.0K
YoY Change 154.8% 123.95% 26.99%
% of Gross Profit 258.94% 291.98% 290.6%
Depreciation & Amortization $142.0K $69.00K $35.00K
YoY Change 102.86% 97.14% 250.0%
% of Gross Profit 19.24% 9.7% 10.97%
Operating Expenses $5.977M $6.730M $4.182M
YoY Change 34.31% 60.93% 60.23%
Operating Profit -$5.239M -$6.019M -$3.863M
YoY Change 31.63% 55.81% 54.52%
Interest Expense $9.000K $13.00K $10.00K
YoY Change 30.0% -90.91%
% of Operating Profit
Other Income/Expense, Net $1.000K $28.00K $1.000K
YoY Change 2700.0%
Pretax Income -$5.229M -$5.991M -$3.860M
YoY Change 46.88% 55.21% 61.51%
Income Tax
% Of Pretax Income
Net Earnings -$5.229M -$5.991M -$3.862M
YoY Change 46.88% 55.13% 61.59%
Net Earnings / Revenue -213.52% -331.91% -383.52%
Basic Earnings Per Share -$0.15
Diluted Earnings Per Share -$128.1K -$148.2K -$106.0K
COMMON SHARES
Basic Shares Outstanding 40.77M 40.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.92M $39.86M $45.10M
YoY Change -16.14% -11.61% 134.16%
Cash & Equivalents $4.937M $9.858M $20.12M
Short-Term Investments $29.98M $30.00M $24.99M
Other Short-Term Assets $868.0K $529.0K $300.0K
YoY Change 14.21% 76.33% 233.33%
Inventory $1.566M $2.284M $1.950M
Prepaid Expenses
Receivables $3.859M $3.257M $1.170M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $41.21M $45.93M $48.53M
YoY Change -12.18% -5.35% 126.56%
LONG-TERM ASSETS
Property, Plant & Equipment $976.0K $888.0K $530.0K
YoY Change 173.39% 67.55% 6.0%
Goodwill
YoY Change
Intangibles $1.982M $1.772M
YoY Change 41.88%
Long-Term Investments
YoY Change
Other Assets $9.000K $8.000K $10.00K
YoY Change -30.77% -20.0% 0.0%
Total Long-Term Assets $3.018M $2.741M $870.0K
YoY Change 58.34% 215.06% 20.83%
TOTAL ASSETS
Total Short-Term Assets $41.21M $45.93M $48.53M
Total Long-Term Assets $3.018M $2.741M $870.0K
Total Assets $44.23M $48.67M $49.40M
YoY Change -9.42% -1.47% 123.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.779M $1.503M $760.0K
YoY Change 44.4% 97.76% 2.7%
Accrued Expenses $824.0K $1.366M $570.0K
YoY Change 14.29% 139.65% 103.57%
Deferred Revenue $155.0K $94.00K
YoY Change 868.75%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $230.0K
YoY Change
Total Short-Term Liabilities $2.857M $3.063M $1.690M
YoY Change 22.09% 81.24% 34.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $190.0K
YoY Change -100.0%
Other Long-Term Liabilities $110.0K $146.0K $80.00K
YoY Change 37.5% 82.5% -55.56%
Total Long-Term Liabilities $110.0K $146.0K $270.0K
YoY Change 39.24% -45.93% 50.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.857M $3.063M $1.690M
Total Long-Term Liabilities $110.0K $146.0K $270.0K
Total Liabilities $2.967M $3.209M $1.960M
YoY Change 22.65% 63.72% 35.17%
SHAREHOLDERS EQUITY
Retained Earnings -$49.76M -$44.53M
YoY Change 96.6%
Common Stock $4.000K $4.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.26M $45.46M $47.44M
YoY Change
Total Liabilities & Shareholders Equity $44.23M $48.67M $49.40M
YoY Change -9.42% -1.47% 123.13%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$5.229M -$5.991M -$3.862M
YoY Change 46.88% 55.13% 61.59%
Depreciation, Depletion And Amortization $142.0K $69.00K $35.00K
YoY Change 102.86% 97.14% 250.0%
Cash From Operating Activities -$4.494M -$3.475M -$3.790M
YoY Change -0.13% -8.31% 82.21%
INVESTING ACTIVITIES
Capital Expenditures -$431.0K -$1.038M -$150.0K
YoY Change -30.48% 592.0% 36.36%
Acquisitions
YoY Change
Other Investing Activities $5.000K -$4.000K -$24.98M
YoY Change -102.38% -99.98%
Cash From Investing Activities -$426.0K -$1.042M -$25.13M
YoY Change -48.67% -95.85% 22745.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.000K 1.325M 13.66M
YoY Change -100.05% -90.3% 16975.0%
NET CHANGE
Cash From Operating Activities -4.494M -3.475M -3.790M
Cash From Investing Activities -426.0K -1.042M -25.13M
Cash From Financing Activities -1.000K 1.325M 13.66M
Net Change In Cash -4.921M -3.192M -15.26M
YoY Change 41.41% -79.08% 623.22%
FREE CASH FLOW
Cash From Operating Activities -$4.494M -$3.475M -$3.790M
Capital Expenditures -$431.0K -$1.038M -$150.0K
Free Cash Flow -$4.063M -$2.437M -$3.640M
YoY Change 4.72% -33.05% 84.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40771708
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40748861
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40748861
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37554162
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37554162
CY2021Q3 wrap Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
1 pure
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M18D
CY2021Q3 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9858000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16647000 USD
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
30004000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
24994000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3257000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1871000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
2284000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2655000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
529000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
760000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
45932000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
46927000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
888000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
73000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
139000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1772000 USD
us-gaap Revenues
Revenues
2529000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1094000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19220000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1397000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13000 USD
CY2021Q3 us-gaap Assets
Assets
48673000 USD
CY2020Q4 us-gaap Assets
Assets
48833000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1503000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1232000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1366000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
721000 USD
CY2021Q3 wrap Current Liabilities Customer Deposits
CurrentLiabilitiesCustomerDeposits
21000 USD
CY2020Q4 wrap Current Liabilities Customer Deposits
CurrentLiabilitiesCustomerDeposits
2000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
94000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
79000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
94000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
275000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3063000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2340000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
146000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56000 USD
CY2021Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
0 USD
CY2020Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
23000 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
146000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
79000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
3209000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2419000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89979000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
71705000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44530000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25310000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
45464000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
46414000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48673000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48833000 USD
CY2021Q3 wrap Product Sales
ProductSales
1719000 USD
CY2020Q3 wrap Product Sales
ProductSales
988000 USD
wrap Product Sales
ProductSales
4997000 USD
wrap Product Sales
ProductSales
2486000 USD
CY2021Q3 us-gaap Other Income
OtherIncome
86000 USD
CY2020Q3 us-gaap Other Income
OtherIncome
19000 USD
us-gaap Other Income
OtherIncome
283000 USD
us-gaap Other Income
OtherIncome
43000 USD
CY2021Q3 us-gaap Revenues
Revenues
1805000 USD
CY2020Q3 us-gaap Revenues
Revenues
1007000 USD
us-gaap Revenues
Revenues
5280000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
170000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-9024000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
688000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3276000 USD
CY2021Q3 wrap Net Unrealized Gain Loss On Short Term Investments
NetUnrealizedGainLossOnShortTermInvestments
-2000 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
us-gaap Gross Profit
GrossProfit
870000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4654000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40413332
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3255000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16210000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7933000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2076000 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36419771
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38767009
us-gaap Gross Profit
GrossProfit
1257000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19220000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9024000 USD
CY2020Q3 wrap Net Unrealized Gain Loss On Short Term Investments
NetUnrealizedGainLossOnShortTermInvestments
7000 USD
wrap Net Unrealized Gain Loss On Short Term Investments
NetUnrealizedGainLossOnShortTermInvestments
-4000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1659000 USD
CY2021Q3 wrap Product Line Exit Expense
ProductLineExitExpense
0 USD
CY2020Q3 wrap Product Line Exit Expense
ProductLineExitExpense
0 USD
wrap Product Line Exit Expense
ProductLineExitExpense
747000 USD
wrap Product Line Exit Expense
ProductLineExitExpense
0 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
1094000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
688000 USD
us-gaap Cost Of Revenue
CostOfRevenue
4023000 USD
us-gaap Cost Of Revenue
CostOfRevenue
1659000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
711000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
319000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
927000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4303000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2038000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6730000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
4182000 USD
us-gaap Operating Expenses
OperatingExpenses
20513000 USD
us-gaap Operating Expenses
OperatingExpenses
9971000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6019000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3863000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-19256000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9101000 USD
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
13000 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
5000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
22000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
81000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
77000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5991000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3862000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32653408
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5991000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3862000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9024000 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
1563000 USD
wrap Common Shares Issued For Services Cash Flow Impact
CommonSharesIssuedForServicesCashFlowImpact
239000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
47437000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19220000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9024000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
336000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-23000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
wrap Common Shares Issued Upon Exercise Of Warrants At8125 Per Share Amount
CommonSharesIssuedUponExerciseOfWarrantsAt8125PerShareAmount
1249000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1678000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
90000 USD
wrap Stock Issued During Period Value Restricted Stock Units Vested
StockIssuedDuringPeriodValueRestrictedStockUnitsVested
0 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
239000 USD
wrap Product Line Exit Expense
ProductLineExitExpense
747000 USD
wrap Product Line Exit Expense
ProductLineExitExpense
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4310000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
17000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 USD
us-gaap Provision For Other Losses
ProvisionForOtherLosses
23000 USD
us-gaap Provision For Other Losses
ProvisionForOtherLosses
17000 USD
wrap Net Unrealized Gain Loss On Short Term Investments
NetUnrealizedGainLossOnShortTermInvestments
7000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5993000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3855000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19224000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9017000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
48755000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1399000 USD
CY2021Q3 wrap Stock Issued During Period Value Restricted Stock Units Vested
StockIssuedDuringPeriodValueRestrictedStockUnitsVested
0 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1303000 USD
CY2021Q3 wrap Net Unrealized Loss On Short Term Investments
NetUnrealizedLossOnShortTermInvestments
2000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5991000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
45464000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
46414000 USD
wrap Common Shares Issued Upon Exercise Of Warrants At650 Per Share Amount
CommonSharesIssuedUponExerciseOfWarrantsAt650PerShareAmount
10799000 USD
wrap Net Unrealized Loss On Short Term Investments
NetUnrealizedLossOnShortTermInvestments
4000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19220000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
45464000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
37084000 USD
CY2020Q3 wrap Common Shares Issued Upon Exercise Of Warrants At300 Per Share Net Of Issuance Costs Amount
CommonSharesIssuedUponExerciseOfWarrantsAt300PerShareNetOfIssuanceCostsAmount
295000 USD
CY2020Q3 wrap Common Shares Issued Upon Exercise Of Warrants At500 Per Share Net Of Issuance Costs Amount
CommonSharesIssuedUponExerciseOfWarrantsAt500PerShareNetOfIssuanceCostsAmount
8366000 USD
CY2020Q3 wrap Common Shares Issued Upon Exercise Of Warrants At600 Per Share Net Of Issuance Costs Amount
CommonSharesIssuedUponExerciseOfWarrantsAt600PerShareNetOfIssuanceCostsAmount
3847000 USD
CY2020Q3 wrap Common Shares Issued Upon Exercise Of Warrants At650 Per Share Amount
CommonSharesIssuedUponExerciseOfWarrantsAt650PerShareAmount
1102000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52000 USD
CY2020Q3 wrap Stock Issued During Period Value Restricted Stock Units Vested
StockIssuedDuringPeriodValueRestrictedStockUnitsVested
0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
546000 USD
CY2020Q3 wrap Net Unrealized Gain On Short Term Investments
NetUnrealizedGainOnShortTermInvestments
7000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3862000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
47437000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
19196000 USD
wrap Sale Of Common Stock And Warrants At600 Per Share In Public Offering Net Of Issuance Costs Amount
SaleOfCommonStockAndWarrantsAt600PerShareInPublicOfferingNetOfIssuanceCostsAmount
11667000 USD
wrap Common Shares Issued Upon Exercise Of Warrants At300 Per Share Net Of Issuance Costs Amount
CommonSharesIssuedUponExerciseOfWarrantsAt300PerShareNetOfIssuanceCostsAmount
735000 USD
wrap Common Shares Issued Upon Exercise Of Warrants At500 Per Share Net Of Issuance Costs Amount
CommonSharesIssuedUponExerciseOfWarrantsAt500PerShareNetOfIssuanceCostsAmount
17234000 USD
wrap Common Shares Issued Upon Exercise Of Warrants At600 Per Share Net Of Issuance Costs Amount
CommonSharesIssuedUponExerciseOfWarrantsAt600PerShareNetOfIssuanceCostsAmount
3847000 USD
wrap Common Shares Issued Upon Exercise Of Warrants At650 Per Share Amount
CommonSharesIssuedUponExerciseOfWarrantsAt650PerShareAmount
1646000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
566000 USD
wrap Stock Issued During Period Value Restricted Stock Units Vested
StockIssuedDuringPeriodValueRestrictedStockUnitsVested
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1563000 USD
wrap Net Unrealized Gain On Short Term Investments
NetUnrealizedGainOnShortTermInvestments
7000 USD
wrap Noncash Lease Expense
NoncashLeaseExpense
67000 USD
wrap Noncash Lease Expense
NoncashLeaseExpense
91000 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
4310000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6511000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25283000 USD
wrap Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
0 USD
wrap Common Shares Issued For Services Cash Flow Impact
CommonSharesIssuedForServicesCashFlowImpact
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1414000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
985000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
160000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-294000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-231000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
50000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
271000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
355000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-71000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-95000 USD
wrap Increase Decrease In The Customer Deposits
IncreaseDecreaseInTheCustomerDeposits
19000 USD
wrap Increase Decrease In The Customer Deposits
IncreaseDecreaseInTheCustomerDeposits
-216000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
502000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
255000 USD
wrap Increase Decrease In Warranty Settlement
IncreaseDecreaseInWarrantySettlement
10000 USD
wrap Increase Decrease In Warranty Settlement
IncreaseDecreaseInWarrantySettlement
2000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
224000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13729000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7693000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
30014000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
24980000 USD
wrap Proceeds From Maturities Of Short Term Investments
ProceedsFromMaturitiesOfShortTermInvestments
25000000 USD
wrap Proceeds From Maturities Of Short Term Investments
ProceedsFromMaturitiesOfShortTermInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
811000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
202000 USD
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
4000 USD
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0 USD
wrap Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
12400000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
733000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
12048000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
24480000 USD
wrap Offering Costs Paid On Exercise Of Warrants
OfferingCostsPaidOnExerciseOfWarrants
-0 USD
wrap Offering Costs Paid On Exercise Of Warrants
OfferingCostsPaidOnExerciseOfWarrants
1017000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1678000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
566000 USD
wrap Proceeds From Bank Note
ProceedsFromBankNote
0 USD
wrap Proceeds From Bank Note
ProceedsFromBankNote
414000 USD
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-275000 USD
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13451000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36110000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-6789000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
3134000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16647000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16984000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9858000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20118000 USD
wrap Change In Unrealized Gain On Short Term Investments
ChangeInUnrealizedGainOnShortTermInvestments
-2000 USD
wrap Change In Unrealized Gain On Short Term Investments
ChangeInUnrealizedGainOnShortTermInvestments
7000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
2655000 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
402000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1342000 USD
CY2021Q3 us-gaap Inventory Gross
InventoryGross
2340000 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
56000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
-0 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
2284000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2655000 USD
CY2021Q2 wrap Write Off Inventory Cost
WriteOffInventoryCost
531000 USD
CY2021Q3 wrap Write Off Inventory Cost
WriteOffInventoryCost
54000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 9pt;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 9pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.</p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5397165
CY2021Q2 wrap Product Line Exit Expense
ProductLineExitExpense
747000 USD
CY2021Q2 wrap Write Off Inventory Cost
WriteOffInventoryCost
531000 USD
wrap Retiring Cost
RetiringCost
106000 USD
CY2021Q2 wrap Raw Material Purchase Reserve
RawMaterialPurchaseReserve
110000 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
56000 USD
CY2021Q2 wrap Product Line Exit Expense
ProductLineExitExpense
747000 USD
CY2020 wrap Product Line Exit Expense
ProductLineExitExpense
0 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
240000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
11000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1796000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1249000 USD
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
142000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
64000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
60000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
223000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
218000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
218000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
218000 USD
CY2021Q3 wrap Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
491000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1428000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
972000 USD
CY2021Q3 wrap Accrued Patent And Legal Costs
AccruedPatentAndLegalCosts
22000 USD
CY2020Q4 wrap Accrued Patent And Legal Costs
AccruedPatentAndLegalCosts
65000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
563000 USD
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
82000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
48000 USD
CY2021Q3 wrap Accrued Consulting Costs
AccruedConsultingCosts
269000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9000 USD
CY2020Q4 wrap Accrued Consulting Costs
AccruedConsultingCosts
2000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.50 pure
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
43000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1366000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
721000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1223000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
574000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
335000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
217000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
888000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
191000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82000 USD
CY2021Q2 us-gaap Production Costs
ProductionCosts
106000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1566000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1076000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
138000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1428000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1053000 USD
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
344000 USD
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
344000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1772000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1397000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
145000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
82000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
79000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070 pure
CY2021Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
21000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
67000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
31000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
91000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
23000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
73000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
34000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
103000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
79000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
79000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
24000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
58000 USD
CY2020 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
298000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
275000 USD
CY2020Q4 wrap Contingent Consideration
ContingentConsideration
23000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.41
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
982500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.57
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
915404
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
319799
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.12
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3678883
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.30
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M19D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3931586
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.46 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0090 pure
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4335000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1904711
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
3493000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0038 pure
wrap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0 pure
wrap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.43
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1303000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
546000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4310000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1562000 USD
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
713000 USD
CY2021Q3 us-gaap Revenues
Revenues
1805000 USD
CY2020Q3 us-gaap Revenues
Revenues
1007000 USD
us-gaap Revenues
Revenues
5280000 USD
us-gaap Revenues
Revenues
2529000 USD

Files In Submission

Name View Source Status
0001851734-21-000017-index-headers.html Edgar Link pending
0001851734-21-000017-index.html Edgar Link pending
0001851734-21-000017.txt Edgar Link pending
0001851734-21-000017-xbrl.zip Edgar Link pending
ex_295146.htm Edgar Link pending
ex_295147.htm Edgar Link pending
ex_295148.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wrap-20210930.xsd Edgar Link pending
wrap-20210930_cal.xml Edgar Link unprocessable
wrap-20210930_def.xml Edgar Link unprocessable
wrap-20210930_lab.xml Edgar Link unprocessable
wrap-20210930_pre.xml Edgar Link unprocessable
wrap.jpg Edgar Link pending
wrap20210930_10q.htm Edgar Link pending
wrap20210930_10q_htm.xml Edgar Link completed